SCHEMBL3655693

SCHEMBL3655693

COc1ccc(C(C)NCc2c(-c3ccccc3)noc2C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
PKM P14618 4/20 0.53
GABRA5 P31644 5/20 0.48
NPSR1 Q6W5P4 1/20 0.48
POLB P06746 1/20 0.46
PTGS2 P35354 1/20 0.45
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 1/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
KMT2A Q03164 2/20 0.43
MITF O75030 1/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2218827 1.00 ALDH1A1 (0.53) ALDH1A1PKMGABRA5NPSR1POLB
SCHEMBL2219161 0.89 ALDH1A1 (0.55) ALDH1A1PKMGABRA5NPSR1PTGS2
SCHEMBL14438335 0.80 ALDH1A1 (0.59) ALDH1A1PKMGABRA5NPSR1PTGS2
SCHEMBL2217114 0.74 GABRA5 (0.48) ALDH1A1PKMGABRA5NPSR1MAPT
SCHEMBL2218694 0.74 PKM (0.46) ALDH1A1PKMNPSR1CYP3A4CYP2C9
SCHEMBL23992068 0.72 CASR (0.70) ALDH1A1PKMPOLBLMNAHTT
SCHEMBL12603184 0.72 CASR (0.70) ALDH1A1PKMPOLBLMNAHTT
SCHEMBL16186450 0.72 CASR (0.70) ALDH1A1PKMPOLBLMNAHTT
SCHEMBL11056381 0.71 KMT2A (0.50) ALDH1A1PKMPOLBPTGS2CYP3A4
SCHEMBL4586989 0.70 PTGS2 (0.88) PTGS2CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212284-A2 CALCIUM RECEPTOR MODULATING AGENTS Amgen Inc. (US) 2010-08-04 EP claimed
WO-2009051718-A2 CALCIUM RECEPTOR MODULATING AGENTS AMGEN INC. (US) 2009-04-23 WO claimed